Wird geladen...
Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation
Although the incidence of bleeding complications during extracorporeal membrane oxygenator (ECMO) support has decreased in various trials, bleeding is still the most fatal complication. We investigated the ideal dosage and efficacy of nafamostat mesilate for use with ECMO in patients with acute card...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The Korean Academy of Medical Sciences
2011
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3124727/ https://ncbi.nlm.nih.gov/pubmed/21738350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2011.26.7.945 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|